Atlas Trials

Neoplasms, Plasma Cell

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms, Plasma Cell

RecordFirmDate
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor (NCT05298683)Hellenic Society of Hematology2022-05-01
A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible (NCT05280275)Hellenic Society of Hematology2022-04-13
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment (NCT05147493)Hellenic Society of Hematology2022-04-01
A Study of Ninlaro in Real World Clinical Practice in China (NCT04328662)Takeda2020-05-18

Track Neoplasms, Plasma Cell automatically

Every clearance here is in the API, with alerts when new ones post.